Cited by 99Mangiferin and Mango ExtractsHeavy Metal Exposure and ToxicityDrug-Induced Hepatotoxicity and Protection

Mangiferin, a natural xanthone, protects murine liver in Pb(II) induced hepatic damage and cell death via MAP kinase, NF-κB and mitochondria dependent pathways

Open access
Pal, Pabitra Bikash, Sinha, Krishnendu, Sil, Parames C.·2013·PLoS ONE

Abstract

One of the most well-known naturally occurring environmental heavy metals, lead (Pb) has been reported to cause liver injury and cellular apoptosis by disturbing the prooxidant-antioxidant balance via oxidative stress. Several studies, on the other hand, reported that mangiferin, a naturally occurring xanthone, has been used for a broad range of therapeutic purposes. In the present study, we, therefore, investigated the molecular mechanisms of the protective action of mangiferin against lead-induced hepatic pathophysiology. Lead [Pb(II)] in the form of Pb(NO3)2 (at a dose of 5 mg/kg body weight, 6 days, orally) induced oxidative stress, hepatic dysfunction and cell death in murine liver. Post treatment of mangiferin at a dose of 100 mg/kg body weight (6 days, orally), on the other hand, diminished the formation of reactive oxygen species (ROS) and reduced the levels of serum marker enzymes [alanine aminotranferase (ALT) and alkaline phosphatase (ALP)]. Mangiferin also reduced Pb(II) induced alterations in antioxidant machineries, restored the mitochondrial membrane potential as well as mutual regulation of Bcl-2/Bax. Furthermore, mangiferin inhibited Pb(II)-induced activation of mitogen-activated protein kinases (MAPKs) (phospho-ERK 1/2, phosphor-JNK phospho- p38), nuclear translocation of NF-κB and apoptotic cell death as was evidenced by DNA fragmentation, FACS analysis and histological assessment. In vitro studies using hepatocytes as the working model also showed the protective effect of mangiferin in Pb(II) induced cytotoxicity. All these beneficial effects of mangiferin contributes to the considerable reduction of apoptotic hepatic cell death induced by Pb(II). Overall results demonstrate that mangiferin exhibit both antioxidative and antiapoptotic properties and protects the organ in Pb(II) induced hepatic dysfunction.

Verifying this paper

8 of 9 steps done · this page updates itself — you can leave and come back

  1. Registry recordVerified
  2. Full textRead the full text
  3. Reference list84 references found
  4. Reference checkChecking each cited work — 84 of 84
  5. StatisticsNeeds the full text
  6. ClaimsNeeds the full text
  7. Cited sourcesNeeds claims to check
  8. Self-checkNeeds the full text
  9. VerificationFindings verified

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0056894

Cites

83 of 84 references verified1 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • MGF's therapeutic actions converge on several core molecular pathways, particularly suppression of oxidative stress and NF-κB-mediated inflammation, and activation of AMPK and SIRT1 signaling.

    “Its therapeutic actions converge on several core molecular pathways, particularly the suppression of oxidative stress and NF-κB-mediated inflammation, and the activation of AMPK and SIRT1 signaling (119-121).”

    From Mangiferin in human disease: Multifaceted mechanisms and applications (Review) (2026) · cites this paper as [119]

    The Results section ('Effect on intracellular ROS production') reports that mangiferin reduced Pb(II)-induced ROS in murine liver, and the Discussion reports suppression of phosphorylated NF-κB in liver and hepatocytes. The paper frames the NF-κB finding as part of protection against hepatic damage and apoptosis, rather than demonstrating reduced NF-κB-mediated inflammation. Searches for AMPK and SIRT1 found no support for activation of either pathway in our copy. (LLM, conf=0.90)

    Experimental — accuracy not yet measured
  • Mangiferin (100 mg/kg, orally for 6 days) inhibits ROS production in lead-induced liver injury.

    “It was revealed that mangiferin (100 mg/kg, orally for 6 days) inhibits ROS production and reduces the levels of serum marker enzymes, such as ALT and ALP.”
  • Mangiferin exhibits antioxidative and antiapoptotic properties via MAPK/NF-κB/mitochondria-dependent pathways in lead-induced liver injury.

    “Overall, it was demonstrated that mangiferin exhibits both antioxidative and antiapoptotic properties via MAPK/NF-κB/mitochondria-dependent pathways (100).”
  • Mangiferin (100 mg/kg, orally for 6 days) reduces serum marker enzymes ALT and ALP in lead-induced liver injury.

    “It was revealed that mangiferin (100 mg/kg, orally for 6 days) inhibits ROS production and reduces the levels of serum marker enzymes, such as ALT and ALP.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

2 retracted

Flagged first, then by citations

Research works printed but not linked: 1

  1. [65]Uchida K, Stadtman ER (1993) Covalent attachment of 4-hydroxynonenal to glyceraldehydes-3-phosphate dehydrogenase. J Biol Chem 268: 6388– 6393. 8454610

Cited by

Sorted by citations

Authors
Pal, P. B., Sinha, K., & Sil, P. C.
Affiliations
Bose Institute (IN)
Corresponding author
Sil, Parames C.
Venue
PLoS ONE
Published
2013-02-25
Volume
8
Issue
2
Pages
e56894
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2010004949
Cited by
98
References
84
Citations by year
2026: 3 · 2025: 5 · 2024: 4 · 2023: 9 · 2022: 5 · 2021: 8 · 2020: 8 · 2019: 8 · 2018: 8 · 2017: 8 · 2016: 9 · 2015: 10 · 2014: 9 · 2013: 4
FWCI
25.22
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Mangiferin and Mango Extracts
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Heavy Metal Exposure and Toxicity
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords
mangiferin, xanthones, lead toxicity, oxidative stress, apoptosis, MAPK signaling, NF-κB, mitochondrial membrane potential, Bcl-2/Bax, reactive oxygen species, hepatoprotection, hepatocytes, hepatocyte cytotoxicity
MeSH terms
Animals, Lead, Liver, Mitochondria, Signal Transduction, NF-kappa B, Mitogen-Activated Protein Kinases, Xanthones, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review